Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer-Reference-Cited by-同舟云学术

Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer

Published:2016-11-02 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Masarwah Amro^ORCID,Auvinen Päivi,Sudah Mazen,Dabravolskaite Vaiva,Arponen Otso,Sutela Anna,Oikari Sanna,Kosma Veli-Matti,Vanninen Ritva

Funder

Kuopio University Hospital VTR Fund

Instrumentarium Foundation

Cancer Center of Eastern Finland

Radiological society of Finland

Finnish Oncological Society

Inkeri and Mauri Vänskä foundation

Suomen Lääketieteen Säätiö (FI)

Suomen Lääketieteen Säätiö

Pohjois-Savon Syöpä yhdistys

Syöpäjärjestöt

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2892-y.pdf

Reference42 articles.

1. Almendro V, Fuster G. Heterogeneity of breast cancer: etiology and clinical relevance. Clin Transl Oncol. 2011;13(11):767–73.

2. Polyak K. Heterogeneity in breast cancer. J Clin Invest. 2011;121(10):3786–8.

3. Balslev I, Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B, Mouridsen HT. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat. 1994;32(3):281–90.

4. Blamey RW, Ellis IO, Pinder SE, Lee AH, Macmillan RD, Morgan DA, Robertson JF, Mitchell MJ, Ball GR, Haybittle JL, Elston CW. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer. 2007;43(10):1548–55.

5. D'Eredita G, Giardina C, Martellotta M, Natale T, Ferrarese F. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer. 2001;37(5):591–6.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics;Cancer Medicine;2024-09

2. Biomarcadores en resonancia magnética y su correlación con el test Oncotype;Radiología;2024-01

3. Mammographic Breast Density and Utility in Breast Cancer Screening and Clinical Decision-Making;Interdisciplinary Cancer Research;2024

4. Handling Class Imbalance Problem using Oversampling Techniques for Breast Cancer Prediction;2023 International Conference on Recent Advances in Electrical, Electronics & Digital Healthcare Technologies (REEDCON);2023-05-01

5. Breast Cancer Survival Analysis with Molecular Subtypes: An Initial Step;2022 IEEE 22nd International Conference on Bioinformatics and Bioengineering (BIBE);2022-11